zadnja posodobitev :
19/11/2024
Infostab
Seznami
Seznami
Poiščite združljivosti
Tabela združljivosti Y-strani
Viri
raziskovalne skupine
valistab
poster
Povezave
sponzorji
Avtor
Navodilo za uporabo
Newsletter
Amphotericin B lipid complex
Kemična formula
Lastniško ime
Sestava pomožnih snovi je med paralelami lahko različna
Abelcet
Argentina, Avstralija, Avstrija, Belgija, Brazilija, Danska, Finska, Francija, Grčija, Irska, Italija, Kanada, Luksemburg, Madžarska, Malezija, Mehika, Nemčija, Nizozemska, Norveška, Peru, Portugalska, Romunija, Španija, Švedska, Velika Britanija, Združene države Amerike
Viri : Amphotericin B lipid complex
Tip
objava
1510
Knjiga
AHFS Formulary service 2000 Bethesda - 3546 p
2247
časopis
Chan P, Heatherly K, Kupiec T.C, Trissel L.A.
Compatibility of caspofungin acetate injection with other drugs during simulated Y-site coadministration.
Int J Pharm Compound 2008 ; 12, 3: 276-278.
2262
časopis
Brammer MK, Chan P, Heatherly K, Trusley C, Kupiec TC, Trissel LA, Psathas PA, Gilmor T, Schaufelberger D.
Compatibility of doripenem with other drugs during simulated Y-site administratioN
Am J Health-Syst Pharm 2008 ; 65: 1261-1265.
3254
časopis
Housman S.T, Tessier P.R, Nicolau D.P, Kuti J.L.
Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administration
Am J Health-Syst Pharm 2011 ; 68: 2265-2270.
3332
Traduction Laboratorij
Tigecycline (Tigacyl®) - Summary of Product characteristics
Pfizer 2012
3644
Traduction Laboratorij
Calcium gluconate® - Summary of Product Characteristics
Hameln Pharmaceuticals 2010
3828
poster
Thabit A.K, Hamada Y, Nicolau D.P.
Ceftozolane/tazobactam physical compatibility during simulated Y-site administration.
ASHP Midyear 2015
3829
poster
So W, Kim L, Thabit A.K, Nicolau D.P, Kuti J.L.
Compatibility of isavunazonium sulfate during simulated Y-site administration.
ASHP Midyear 2015
4055
časopis
Monogue M, Almarzoky Abuhussain S, Kuti J, Nicolau D.
Physical compatibility of fosfomycin for injection with select i.v. drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2018 , 75, 1:36-44
Mentions Légales